» Articles » PMID: 7173716

Intragastric Nitrites, Nitrosamines, and Bacterial Overgrowth During Cimetidine Treatment

Overview
Journal Gut
Specialty Gastroenterology
Date 1982 Dec 1
PMID 7173716
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

A six week course of cimetidine (1 g/day) healed peptic ulcers in 20 of 23 patients (14 with duodenal ulcer, nine with gastric ulcer). Reduction of basal acid output by 73% and peak acid output by 36% led to a rise in concentrations of intragastric aerobic bacteria and nitrate-reducing bacteria. While the mean intragastric concentration of nitrate was unchanged by treatment, there were statistically significant rises in nitrite and N-nitrosamine concentrations. The conversion from nitrates to nitrites was closely related to the occurrence of nitrate-reducing bacteria. In three patients the intragastric milieu had returned to normal two months after cimetidine treatment had been discontinued. Mean nitrite and N-nitrosamine concentrations did not return to pre-treatment levels in the group of eight patients who remained on maintenance cimetidine (0.4 g at night-time) for three months after the full dose treatment. This study shows that cimetidine treatment can create an intragastric milieu resembling that of atrophic gastritis. Large scale and long-term studies are necessary to establish whether these findings have any clinical significance.

Citing Articles

Correlation Between Gastroesophageal Reflux Disease and Small Intestinal Bacterial Overgrowth: Analysis of Intestinal Microbiome and Metabolic Characteristics.

Wang Z, Tan W, Huang J, Zhang P, Li Q, Wang M J Inflamm Res. 2025; 18():33-51.

PMID: 39780983 PMC: 11708204. DOI: 10.2147/JIR.S487185.


Use of proton pump inhibitors for the risk of gastric cancer.

Gao H, Li L, Geng K, Teng C, Chen Y, Chu F Medicine (Baltimore). 2023; 101(49):e32228.

PMID: 36626449 PMC: 9750528. DOI: 10.1097/MD.0000000000032228.


The interplay between and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis.

Fakharian F, Asgari B, Nabavi-Rad A, Sadeghi A, Soleimani N, Yadegar A Front Cell Infect Microbiol. 2022; 12:953718.

PMID: 36046747 PMC: 9423097. DOI: 10.3389/fcimb.2022.953718.


Cow's milk protein allergy in a neonate presenting with methaemoglobinaemia.

Kurian S, Panigrahy N, Jamalpuri V, Chirla D BMJ Case Rep. 2022; 15(8).

PMID: 35985742 PMC: 9396161. DOI: 10.1136/bcr-2021-246599.


The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis.

Song H, Jeon N, Squires P Eur J Clin Pharmacol. 2020; 76(10):1437-1456.

PMID: 32548678 DOI: 10.1007/s00228-020-02927-8.


References
1.
Drasar B, SHINER M, McLeod G . Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology. 1969; 56(1):71-9. View

2.
Hassan M, Hobsley M . Positioning of subject and of nasogastric tube during a gastric secretion study. Br Med J. 1970; 1(5694):458-60. PMC: 1699461. DOI: 10.1136/bmj.1.5694.458. View

3.
Siurala M, Lehtola J, Ihamaki T . Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol. 1974; 9(5):441-6. View

4.
Longstreth G, Go V, Malagelada J . Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer. N Engl J Med. 1976; 294(15):801-4. DOI: 10.1056/NEJM197604082941502. View

5.
Pounder R, G Williams J, Misiewicz J . Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut. 1976; 17(2):133-8. PMC: 1411087. DOI: 10.1136/gut.17.2.133. View